:be Aktie
WKN DE: A3CWWB / ISIN: AT0000A2SGH0
29.06.2024 14:55:00
|
Where Will Novavax Be in 1 Year?
What a difference a few months make. Vaccine specialist Novavax (NASDAQ: NVAX) started the year poorly, continuing with the issues it has encountered since mid-2021.Those headwinds included the difficulties it faced in launching its COVID vaccine in the U.S. and the significant slowdown in demand for these products, leading to a decline in revenue and earnings for the biotech.However, several developments have jolted Novavax's stock since January. The company's shares are up by just under 200% this year. Can it keep up that momentum through the next 12 months? Let's find out.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu :be AG Inhaber-Aktmehr Nachrichten
Analysen zu :be AG Inhaber-Aktmehr Analysen
Aktien in diesem Artikel
:be AG Inhaber-Akt | 0,20 | 0,00% |
|
IN Holdings Co. LTD. Registered Shs | 220,00 | 0,00% |
|
Novavax Inc. | 5,50 | 0,11% |
|